Filtering by:
GeneticsShould You Get Genetic Testing for Cancer Risk?
Most cancers are not caused by inherited gene mutations. But if cancer runs in your family, you may want to consider genetic testing options.
FDA Approves Consumer Test for Certain BRCA Mutations
The US Food and Drug Administration (FDA) has approved the first direct-to-consumer tests for certain BRCA1 and BRCA2 gene mutations.
Liquid Biopsies: Past, Present, and Future
In the future, doctors may be able to use a simple blood test to screen for several types of cancer. Right now, a lot of research is going on using cell-free DNA, circulating tumor DNA, and protein biomarkers for cancer. Dr. Len Lichtenfeld, deputy chief medical officer of the American Cancer Society, shares his insights on what's been done, and what it will take, to make sure such a test is useful to doctors and patients before it goes to market.
What to Know Before Buying a Home DNA Test
Experts advise caution before buying an online service that tests your DNA and mails you back results regarding certain genetic health risks or inherited conditions.
How Family History 'Really' Affects Your Cancer Risk
Cancer can seem to run in some families, but most cancer is not inherited. Check your knowledge about common myths concerning cancer and family history.
Genetic Testing and Counseling for Breast Cancer Can Help Guide Tough Decisions
Genetic testing can answer some of the questions faced by women newly diagnosed with breast cancer. But what precedes and follows that test is vital, experts say. Many women have been helped by genetic counseling, a detailed discussion by a trained professional of a woman’s specific circumstances.
Women Face Gaps in Use of Genetic Counseling to Make Breast Cancer Treatment Decisions
Genetic testing is an important tool in making breast cancer treatment decisions, and it's more widely available today than ever before. But many women are still not getting all the information they need.
FDA Approves New Targeted Therapy Drug Combination for Lung Cancer
The US Food and Drug Administration (FDA) has approved the targeted therapy drugs Tafinlar (dabrafenib) and Mekinist (trametinib) to be used together to treat people with a specific type of non-small cell lung cancer that has spread in the body (metastasized).